Changes in cerebral oxygenation by phenylephrine or ephedrine
Not Applicable
- Conditions
- Patients scheduled to have laparoscopic surgery
- Registration Number
- JPRN-UMIN000033310
- Lead Sponsor
- Hokkaido University Hospital Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients with cardiovascular disease 2 Patients with cerebral disorders 3 Patients with uncontrolled DM (HbA1c>7)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in cerebral oxygenation
- Secondary Outcome Measures
Name Time Method Changes in cerebral hemoglobin concentration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie phenylephrine and ephedrine's effects on cerebral oxygenation in laparoscopic surgery patients?
How do phenylephrine and ephedrine compare to standard vasopressors in maintaining cerebral oxygenation during laparoscopic surgery?
Which biomarkers predict response to phenylephrine or ephedrine in cerebral oxygenation during laparoscopic procedures?
What adverse events are associated with phenylephrine and ephedrine in laparoscopic surgery, and how are they managed?
Are there combination therapies with phenylephrine or ephedrine that improve cerebral oxygenation in surgical patients?